Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcoma
Phase 2
Recruiting
- Conditions
- advanced bone and soft tissue tumor
- Registration Number
- JPRN-UMIN000021202
- Lead Sponsor
- agoya City University, Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Past history of allegy for gemcitabine or docetaxel 2) Interstitial pneumonitis or pulmonary fibrosis 3) Active infection 4) Pregnancy 5) Lactation 6) Double cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression-free survival
- Secondary Outcome Measures
Name Time Method adverse effect